Who is sponsoring NCT02199015?

NCT02199015 is sponsored by Juan Carlos M. Andreani MD.

What drugs are being tested in NCT02199015?

Interventions in NCT02199015: Lateral spinal cord surgical implant of electrodes.

What condition does NCT02199015 study?

NCT02199015 studies Cerebral Palsy, Spasticity.

Is NCT02199015 still recruiting?

NCT02199015 is currently not yet recruiting. Last updated 21 November 2023.

Last reviewed 2023-11-21 · How we verify

NCT02199015: Andreani1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy

Not yet recruiting NA Last updated 21 November 2023

What this trial tests

NA trial testing Lateral spinal cord surgical implant of electrodes in Cerebral Palsy in 40 participants. Not yet recruiting.

Timeline

1 June 2025

Primary endpoint
1 April 2027

31 December 2027

Quick facts

Lead sponsor	Juan Carlos M. Andreani MD
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 June 2025
Primary completion	1 April 2027
Estimated completion	31 December 2027
Sites	2 locations across Argentina, Germany

Drugs / interventions tested

Lateral spinal cord surgical implant of electrodes

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →
Spasticity — all drugs for Spasticity →

Sponsor

Juan Carlos M. Andreani MD

Who can join

16 and older, any sex, with Cerebral Palsy or Spasticity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our work is to investigate whether electrical Lateral Cord Stimulation (LCS) causes an inhibitory and modulatory action by indirect cerebellar activation, so releasing spasticity and the spastic syndrome in selected cases of patients with cerebral palsy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02199015 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Juan Carlos M. Andreani MD
Last refreshed: 21 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02199015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing